Related Experiment Video
Updated: Apr 20, 2026

06:45
Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
15.8K
A structured loop modulates coupling between the substrate-binding and dimerization domains in the multidrug
James R Banigan1, Anindita Gayen1, Min-Kyu Cho1
1From the Department of Chemistry, New York University, New York, New York 10003.
The Journal of Biological Chemistry
|November 20, 2014
Summary
The small multidrug resistance (SMR) protein EmrE
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Secondary active transporters, including the small multidrug resistance (SMR) family, are crucial for moving substrates across cell membranes.
- SMR proteins, like EmrE, are small, dimeric transporters with four transmembrane domains, but the mechanism coupling the dimerization domain (TM4) to the substrate-binding site (TM1-3) remains unclear.
Purpose of the Study:
- To investigate the structure-function relationship of the loop connecting TM3 and TM4 in the SMR protein EmrE.
- To elucidate how this loop mediates conformational changes essential for ion-coupled drug efflux.
Main Methods:
- Solid-state NMR spectroscopy was employed to determine the secondary structure of the EmrE loop in lipid bilayers.
- Structure-function analyses were performed using EmrE mutants in resistance assays in Escherichia coli.
Main Results:
- Solid-state NMR revealed a β-strand secondary structure for the loop connecting TM3 and TM4.
- Mutational analysis showed that both the length and specific residue composition of this loop are critical for EmrE function.
- Altering the loop length or replacing a key hydrophobic residue with glycine abolished ethidium resistance.
Conclusions:
- The loop connecting TM3 and TM4 in EmrE is a structured element essential for ion-coupled transport.
- This structured linker likely plays a conserved role across the SMR family in mediating the conformational switches required for drug efflux.
- Loops in transport proteins can be critical functional components, not just passive linkers.
Related Concept Videos
Cooperative Allosteric Transitions
9.5K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.5K
Membrane Asymmetry Regulating Transporters
8.1K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
8.1K
Transducer Mechanism: Enzyme-Linked Receptors
5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.1K
Insertion of Multi-pass Transmembrane Proteins in the RER
19.9K
The rough ER membrane synthesizes, assembles, and embeds transmembrane proteins in diverse topologies. These proteins function as transporters or channels and can remain in the ER membrane or are sent to the Golgi complex, lysosome, and cell membrane.
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
19.9K
Ligand Binding and Linkage
6.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Cellular Membranes and Drug Transport
2.3K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.3K

